Clozaril (HLS Therapeutics (USA), Inc.)
Welcome to the PulseAid listing for the Clozaril drug offered from HLS Therapeutics (USA), Inc.. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | HLS Therapeutics (USA), Inc. |
| NON-PROPRIETARY NAME: | clozapine |
| SUBSTANCE NAME: | CLOZAPINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Atypical Antipsychotic [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-05-06 |
| END MARKETING DATE: | 0000-00-00 |
Clozaril HUMAN PRESCRIPTION DRUG Details:
| Item Description | Clozaril from HLS Therapeutics (USA), Inc. |
| LABELER NAME: | HLS Therapeutics (USA), Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2016-05-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69809-0126_3113b407-0589-16dd-a1c7-a8301652a29a |
| PRODUCT NDC: | 69809-0126 |
| APPLICATION NUMBER: | NDA019758 |
Other CLOZAPINE Pharmaceutical Manufacturers / Labelers:
